July 21, 2024, 07:32:06 PM
Forum Rules: Read This Before Posting

Topic: Dapagliflozin>98% (HPLC) | [CAS 461432-26-8] | Sun-shinechem|  (Read 4613 times)

0 Members and 1 Guest are viewing this topic.

Offline sun-shine

  • Regular Member
  • ***
  • Posts: 24
  • Mole Snacks: +0/-0
purity>98 , %;
in stock!

Dapagliflozin (rINN/USAN)is an experimental drug being studied by Bristol-Myers Squibb in partnership with AstraZeneca as a potential treatment for type 1[1] and 2 diabetes. Although dapagliflozin's method of action would operate on either type of diabetes or other conditions resulting in hyperglycemia, the current clinical trials specifically exclude participants with Type 1 diabetes

Sponsored Links